Dyson J E, Corbett P J
Br J Cancer. 1978 Sep;38(3):401-10. doi: 10.1038/bjc.1978.221.
We have determined that when an extract of human brain is preincubated with lymphocytes its subsequent capacity to inhibit the electrophoretic mobility of tanned and stabilized erythrocytes is much reduced. There is a differential effect, however, as the observed reduction is from 73% inhibition to approximately 35% when the pre-incubation is with lymphocytes from patients with malignant disease, but from 73% to approximately 10% when it is with lymphocytes from normal controls. These values were obtained at a brain extract concentration of 333 microgram/ml, with 5 times 10(6) lymphocytes, a pre-incubation time of 18-24 h, and a temperature of 27 degrees C, which are the optimum conditions determined for differentiation between cancer patients and normal subjects. In a series of 73 subjects tested by this method 43/51 cancer patients gave an unequivocal "positive" value, 22/22 normal controls gave a "negative" value, with no false positives.
我们已经确定,当人脑提取物与淋巴细胞进行预孵育时,其随后抑制鞣酸处理并稳定化的红细胞电泳迁移率的能力会大大降低。然而,存在差异效应,当与恶性疾病患者的淋巴细胞进行预孵育时,观察到的抑制率从73%降至约35%,而当与正常对照的淋巴细胞进行预孵育时,抑制率从73%降至约10%。这些值是在脑提取物浓度为333微克/毫升、淋巴细胞数量为5×10⁶、预孵育时间为18 - 24小时以及温度为27℃的条件下获得的,这些是确定区分癌症患者和正常受试者的最佳条件。通过这种方法对73名受试者进行测试,51名癌症患者中有43名给出明确的“阳性”值,22名正常对照均给出“阴性”值,无假阳性结果。